Hepatitis C virus (HCV) screening

September 9, 2026

Medicare covers hepatitis C virus screening for certain adult Medicare beneficiaries who fall into at least one of the following categories:

High risk for HCV infection
Born between 1945 and 1965
Had a blood transfusion before 1992

HCPCS/CPT code

G0472 - Hepatitis C antibody screening, for individuals at high risk and other covered indication(s)
G0567 - Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique (effective date of service June 27, 2024)

Place of service (POS)

11 - Physician's office
19 - Off campus - outpatient hospital
22 - On campus - outpatient hospital
49 - Independent clinic
71 - State or local public health clinic
81 - Independent laboratory

Frequency

Once for Medicare beneficiaries born from 1945 through 1965 who are not considered high risk (use ICD-10 Z11.59; effective October 1, 2017)
An initial screening for Medicare beneficiaries, regardless of birth year, for adults at high risk, that is, beneficiaries who had a blood transfusion before 1992 and beneficiaries with a current or past history of illicit injection drug use
Annually only for high-risk Medicare beneficiaries with continued illicit injection drug use since the prior negative (HCV) screening test

Deductible and coinsurance are waived for this service.

References